News & Events :: Can-Fite BioPharma Ltd. (CANF)

Recent News View All News

May 5, 2025 8:00am EDT

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

Apr 17, 2025 8:55am EDT

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Upcoming Events View IR Calendar

Jun 23, 2025 3:00 pm IDT

2025 Annual General Meeting of Shareholders

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings